With the expansion of the My Pharmacy feature, patients can use Propeller to refill prescriptions with five of the seven largest pharmaceutical providers in the U.S.
MADISON, Wis., November 19, 2019 — Propeller Health, a leading digital health company dedicated to the management of asthma and chronic obstructive pulmonary disease (COPD), announced that users are now able to access pharmacy services from CVS, Walmart, Kroger and Rite Aid directly from the Propeller app.
In January 2019, Propeller announced the launch of My Pharmacy, an in-app feature that allows users to manage their prescription refills for asthma and COPD and locate a nearby pharmacy from the Propeller app.
My Pharmacy launched initially with Walgreens, and has now expanded to include CVS, Walmart, Kroger and Rite Aid, five of the seven largest pharmaceutical providers in the U.S. representing more than 50 percent of total U.S. market share for prescription pharmaceuticals, according to Drug Channels Institute.
“We know that medication management can be an additional burden for people living with asthma and COPD,” said Greg Tracy, chief technology officer of Propeller Health. “We hope that creating a convenient way to refill prescriptions and locate nearby pharmacies from the Propeller app makes life easier for our users.”
Propeller is a digital health tool that helps people with asthma or COPD manage their condition in partnership with their doctor. Propeller sensors attach to patients’ existing inhalers and deliver insights on medication use, symptom triggers and environmental factors to the Propeller app on their smartphone, which they can then share with their clinician to help inform their treatment plan.
The update will also allow users to select their preferred pharmacy to display in the Records tab of the app. Propeller users can access the newly connected pharmacy services in the app starting this week.
About Propeller Health
Propeller Health is a leading digital health company dedicated to making life better for every person with chronic respiratory disease. Propeller creates products to more effectively treat chronic respiratory disease and improve clinical outcomes for patients through connectivity, analytics, and companion digital experiences. The Propeller platform is used by patients, physicians and healthcare organizations in the United States, Europe and Asia. Propeller Health is a wholly owned subsidiary of ResMed (NYSE: RMD, ASX: RMD). For more information, visit http://www.propellerhealth.com